Choreo LLC’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
14,171
+515
+4% +$11.9K ﹤0.01% 1197
2026
Q1
$281K Buy
13,656
+260
+2% +$5.86K ﹤0.01% 1290
2025
Q4
$320K Buy
13,396
+1,141
+9% +$27.8K ﹤0.01% 1184
2025
Q3
$305K Sell
12,255
-13,903
-53% -$299K ﹤0.01% 1216
2025
Q2
$602K Buy
26,158
+1,976
+8% +$45.8K 0.01% 799
2025
Q1
$543K Buy
24,182
+2,341
+11% +$54.4K 0.01% 789
2024
Q4
$425K Buy
21,841
+1,752
+9% +$34.7K 0.01% 985
2024
Q3
$353K Buy
20,089
+1,156
+6% +$22.1K 0.01% 1104
2024
Q2
$324K Buy
+18,933
New +$335K 0.01% 1060

Other funds holding PRVA

Choreo LLC's PRVA Position: Q2 2026 in Review

Choreo LLC increased its Privia Health (PRVA) stake by 3.8% in Q2 2026, buying an estimated $11.9K and bringing the position to 14,171 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.

Choreo LLC first reported a position in PRVA in Q2 2024 and has held it in 9 quarters since. The position peaked at $602K in Q2 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Choreo LLC held 14,171 shares of Privia Health worth $365K as of Q2 2026.
  • Choreo LLC bought 515 Privia Health shares in Q2 2026, an estimated $11.9K.
  • Privia Health made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1197 holding.
  • Choreo LLC first reported a position in Privia Health in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Privia Health position peaked at $602K in Q2 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.